Related scientific articles (all)

A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints.

Authors : Fumagalli D, Bedard PL, Nahleh Z, Michiels S, Sotiriou C, Loi S, Sparano JA, Ellis M, Hylton N, Zujewski JA, Hudis C, Esserman L, Piccart-Gebhart M
Year : 2012
Journal : Lancet Oncol
Volume : 13(6)
Pages : e240-8

Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling.

Authors : Azim HA, Michiels S, Bedard PL, Singhal SK, Criscitiello C, Ignatiadis M, Haibe-Kains B, Piccart-Gebhart M, Sotiriou C, Loi S
Year : 2012
Journal : Clin Cancer Res
Volume : 18(5)
Pages : 1341-51

Characterization and clinical evaluation of CD10+ stroma cells in the breast cancer microenvironment.

Authors : Desmedt C, Majjaj S, Kheddoumi N, Singhal SK, Haibe-Kains B, El Ouriaghli F, Chaboteaux C, Michiels S, Lallemand F, Journe F, Duvillier H, Loi S, Quackenbush J, Dekoninck S, Blanpain C, Lagneaux L, Houhou N, Delorenzi M, Larsimont D, Piccart-Gebhart M, Sotiriou C
Year : 2012
Journal : Clin Cancer Res
Volume : 18(4)
Pages : 1004-14

A three-gene model to robustly identify breast cancer molecular subtypes.

Authors : Haibe-Kains B, Desmedt C, Loi S, Culhane AC, Bontempi G, Quackenbush J, Sotiriou C
Year : 2012
Journal : J. Natl. Cancer Inst.
Volume : 104(4)
Pages : 311-25

The landscape of cancer genes and mutational processes in breast cancer.

Authors : Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, Wedge DC, Nik-Zainal S, Martin S, Varela I, Bignell GR, Yates LR, Papaemmanuil E, Beare D, Butler A, Cheverton A, Gamble J, Hinton J, Jia M, Jayakumar A, Jones D, Latimer C, Lau KW, McLaren S, McBride DJ, Menzies A, Mudie L, Raine K, Rad R, Chapman MS, Teague J, Easton D, Langerød A, Lee MT, Shen CY, Tee BT, Huimin BW, Broeks A, Vargas AC, Turashvili G, Martens J, Fatima A, Miron P, Chin SF, Thomas G, Boyault S, Mariani O, Lakhani SR, van de Vijver M, + collaborators (among others :, Desmedt C, Sotiriou C, Stratton MR
Year : 2012
Journal : Nature
Volume : 486(7403)
Pages : 400-4

Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis.

Authors : Ignatiadis M, Singhal SK, Desmedt C, Haibe-Kains B, Criscitiello C, Andre F, Loi S, Piccart-Gebhart M, Michiels S, Sotiriou C
Year : 2012
Journal : J. Clin. Oncol.
Volume : 30(16)
Pages : 1996-2004

Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions.

Authors : Pradeep CR, Zeisel A, Köstler WJ, Lauriola M, Jacob-Hirsch J, Haibe-Kains B, Amariglio N, Ben-Chetrit N, Emde A, Solomonov I, Neufeld G, Piccart-Gebhart M, Sagi I, Sotiriou C, Rechavi G, Domany E, Desmedt C, Yarden Y
Year : 2012
Journal : Oncogene
Volume : 31(31)
Pages : 3569-83

Molecular biology in breast cancer: Should molecular classifiers be assessed by conventional tools or by gene expression arrays?

Authors : Fumagalli D, Andre F, Piccart-Gebhart M, Sotiriou C, Desmedt C
Year : 2012
Journal : Crit Rev Oncol Hematol
Volume : 84 supl 1
Pages : e58-69

International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010).

Authors : Berruti A, Generali D, Kaufmann M, Puztai L, Curigliano G, Aglietta M, Gianni L, Miller WR, Untch M, Sotiriou C, Daidone M, Conte P, Kennedy D, Damia G, Petronini P, Di Cosimo S, Bruzzi P, Dowsett M, Desmedt C, Mansel RE, Olivetti L, Tondini C, Sapino A, Fenaroli P, Tortora G, Thorne H, Bertolini F, Ferrozzi F, Danova M, Tagliabue E, de Azambuja E, Makris A, Tampellini M, Dontu G
Year : 2011
Journal : J. Natl. Cancer Inst. Monographs
Volume : 2011(43)
Pages : 147-51

Multifactorial approach to predicting resistance to anthracyclines.

Authors : Desmedt C, Di Leo A, de Azambuja E, Larsimont D, Haibe-Kains B, Selleslags J, Delaloge S, Duhem C, Kains JP, Carly B, Maerevoet M, Vindevoghel A, Rouas G, Lallemand F, Durbecq V, Cardoso F, Salgado R, Rovere R, Bontempi G, Michiels S, Buyse M, Nogaret JM, Qi Y, Symmans F, Pusztai L
Year : 2011
Journal : J. Clin. Oncol.
Volume : 29(12)
Pages : 1578-86

Beyond trastuzumab: new treatment options for HER2-positive breast cancer.

Authors : Saini KS, Azim HA, Metzger-Filho O, Loi S, Sotiriou C, de Azambuja E, Piccart-Gebhart M
Year : 2011
Journal : Breast
Volume : 20 Suppl 3
Pages : S20-7

Introduction to Gene Expression Profiling In Breast Cancer in “Breast Surgical techniques and Interdisciplinary Management”, (TEXTBOOK Dirbas FM. & Scott-Conner C.E.H. Editors (Springer, 2011 - 440 pages).

Authors : Dirbas FM, Sotiriou C
Year : 2011
Journal : Book
Volume : -
Pages : -

HER2-overexpressing breast cancer: time for the cure with less chemotherapy?

Authors : Loi S, de Azambuja E, Pugliano L, Sotiriou C, Piccart-Gebhart M
Year : 2011
Journal : Curr Opin Oncol
Volume : 23(6)
Pages : 547-58

Outils génomiques pouvant aider au choix thérapeutique des cancers du sein – Analyse in « Cancer du Sein : compte-rendu du 12ème Cours francophone supérieur de cancérologie – (TEXTBOOK : Nice, St-Paul de Vence, Janvier 19-22, 2011 » Namer M., Héry M.

Authors : Ignatiadis M, Sotiriou C
Year : 2011
Journal : Book
Volume : -
Pages : 311-16

Proteomic changes associated with breast cancer progression in the MCF10AT model.

Authors : Fumagalli D, Michiels S, Sotiriou C
Year : 2011
Journal : Pharmacogenomics
Volume : 12(1)
Pages : 9-10

A time series evaluation of the in vivo effect of letrozole on gene expression in breast cancer.

Authors : Fumagalli D, Michiels S, Sotiriou C
Year : 2011
Journal : Pharmacogenomics
Volume : 12(1)
Pages : 10

Gene-expression changes over time in a tamoxifen-treated breast cancer xenograft model.

Authors : Fumagalli D, Michiels S, Sotiriou C
Year : 2011
Journal : Pharmacogenomics
Volume : 12(1)
Pages : 11

CD44+ CD24-/low phenotype and resistance to trastuzumab in HER2-positive breast cancer cell lines.

Authors : Fumagalli D, Michiels S, Sotiriou C
Year : 2011
Journal : Pharmacogenomics
Volume : 12(1)
Pages : 12-3

Genomic Grade Index: An important tool for assessing breast cancer tumor grade and prognosis.

Authors : Filho OM, Ignatiadis M, Sotiriou C
Year : 2011
Journal : Crit Rev Oncol Hematol
Volume : 77(1)
Pages : 20-9

ZNF703 gene amplification at 8p12 specifies luminal B breast cancer.

Authors : Sircoulomb F, Nicolas N, Ferrari A, Finetti P, Bekhouche I, Rousselet E, Lonigro A, Adélaïde J, Baudelet E, Esteyriès S, Wicinski J, Audebert S, Charafe-Jauffret E, Jacquemier J, Lopez M, Borg JP, Sotiriou C, Popovici C, Bertucci F, Birnbaum D, Chaffanet M, Ginestier C
Year : 2011
Journal : EMBO Mol Med
Volume : 3(3)
Pages : 153-66